
Danaher Corporation DHR
$ 189.77
-0.12%
Annual report 2025
added 02-24-2026
Danaher Corporation Cash Conversion Cycle 2011-2026 | DHR
Annual Cash Conversion Cycle Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77.5 | 83.5 | 93.5 | 79.1 | 72.3 | 65.9 | 70.3 | 72.2 | 85 | 79.7 | 72.1 | 64.9 | 66.1 | 76.3 | 85.7 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 93.5 | 64.9 | 76.3 |
Quarterly Cash Conversion Cycle Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84.3 | - | - | - | - | 76 | 67.6 | - | -12.8 | 26.6 | 65.5 | - | -7.61 | -6.79 | 29.5 | 59.8 | -4.84 | -4.96 | 33.5 | 55.5 | -6.66 | -8.3 | 37.4 | 63.2 | 86.2 | 83.3 | 84.5 | 63.4 | 81.5 | 79.5 | 82.3 | 63 | 96.7 | 74.8 | 72.1 | 60.2 | 66.9 | 65.1 | 66.8 | 61 | 67.7 | 66.7 | 74.8 | 59.9 | 78.9 | 76.6 | 80.5 | 59 | 77.1 | 95.6 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 96.7 | -12.8 | 56.2 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
111 | $ 112.78 | 0.68 % | $ 34.3 B | ||
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Biomerica
BMRA
|
172 | $ 2.13 | - | $ 4.89 M | ||
|
Fulgent Genetics
FLGT
|
42.4 | $ 16.31 | -0.12 % | $ 493 M | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
Lantheus Holdings
LNTH
|
97.3 | $ 74.22 | -1.99 % | $ 5.01 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 457.05 | 0.03 % | $ 13.2 B | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 242.53 | 0.28 % | $ 25.6 B | ||
|
Myriad Genetics
MYGN
|
49.3 | $ 4.59 | -1.61 % | $ 425 M | ||
|
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | ||
|
Pacific Biosciences of California
PACB
|
185 | $ 1.37 | -1.8 % | $ 411 M | ||
|
Co-Diagnostics
CODX
|
299 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
Precipio
PRPO
|
-3.19 | $ 26.85 | -0.3 % | $ 34.8 M | ||
|
Personalis
PSNL
|
-11.5 | $ 7.51 | -1.38 % | $ 445 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
RadNet
RDNT
|
34.5 | $ 59.53 | -3.58 % | $ 4.48 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 157.49 | -0.32 % | $ 7.81 B | ||
|
IQVIA Holdings
IQV
|
73.9 | $ 164.98 | -1.19 % | $ 28.4 B | ||
|
Senseonics Holdings
SENS
|
36.1 | $ 6.58 | -0.6 % | $ 275 M | ||
|
Sotera Health Company
SHC
|
33.5 | $ 13.78 | -0.76 % | $ 3.91 B | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
166 | $ 1.21 | -17.47 % | $ 6.59 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 17.47 | -0.26 % | $ 391 M | ||
|
Neuronetics
STIM
|
17.3 | $ 1.54 | -4.06 % | $ 102 M | ||
|
Interpace Biosciences
IDXG
|
44.9 | $ 1.71 | 0.73 % | $ 7.5 M | ||
|
IDEXX Laboratories
IDXX
|
103 | $ 572.18 | -1.09 % | $ 46 B | ||
|
Illumina
ILMN
|
142 | $ 124.58 | 0.64 % | $ 19.8 B | ||
|
ICON Public Limited Company
ICLR
|
62 | $ 99.8 | -0.55 % | $ 8.23 B | ||
|
Guardant Health
GH
|
79.6 | $ 82.96 | -2.36 % | $ 10.4 B | ||
|
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
83.6 | $ 44.3 | -0.45 % | $ 2.65 B | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 263.8 | -0.23 % | $ 21.9 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
ENDRA Life Sciences
NDRA
|
-1.24 K | $ 3.41 | -2.16 % | $ 1.83 M | ||
|
NeoGenomics
NEO
|
82.4 | $ 7.9 | -2.47 % | $ 1.01 B | ||
|
Natera
NTRA
|
81.5 | $ 194.02 | -3.03 % | $ 19.1 B | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 17.35 | -1.2 % | $ 925 M | ||
|
OPKO Health
OPK
|
242 | $ 1.14 | -1.3 % | $ 791 M |